FDA makes it official, once again rejecting battered Correvio’s heart drug
Thirteen years after Correvio first tried — and failed — to gain an approval for the heart drug vernakalant, the FDA has handed them their latest CRL …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
